What the guidelines, the trials and the FDA label record state about hormone preparations
Hormone evidence: what the endocrine guidelines, the position statements, the large trials and the FDA label record state about testosterone, estradiol, progesterone, DHEA and thyroid preparations.
Written for licensed practitioners; every page reports its sources as written and leaves the prescribing decision to the practitioner.
The references, in reading order
3 references, each with numbered citations to the guidelines, trials and agency documents.
Guidelines, trials and the label record
What the specialty societies set for diagnosis and monitoring, what the large trials reported, and where the FDA label and the National Academies stand on approved and compounded preparations.
Testosterone Therapy: Guidelines and TRAVERSE
The guidelines, the TRAVERSE result and the FDA label, as the sources state them.
Menopausal Hormone Therapy: Position Statements
The 2022 position statement, the WHI record and the FDA label, as written.
Compounded Bioidentical Hormones: NASEM 2020
The NASEM 2020 conclusions and FDA's position on compounded hormone products.
This page is provided for informational purposes only. It is not medical advice, it is not intended to diagnose, treat, cure, or prevent any disease, and it is not a substitute for the judgment of a licensed practitioner. Consult a healthcare professional before acting on anything stated here. ExaVeyra Sciences is a supplier and takes no part in any diagnosis, treatment decision, or plan of care. These references report what endocrine guidelines, position statements, trials and FDA labeling state about hormone preparations, for professional education, and make no statement about the suitability of any product for any patient. Where this page discusses an FDA-approved product, the approved labeling governs and nothing here modifies it. Compounded medications are a separate product class: they are not FDA-approved finished drug products, they are prepared under section 503A of the Federal Food, Drug, and Cosmetic Act against a prescription for an individual patient, and they are prescription products supplied to licensed practitioners only. Where a controlled substance such as testosterone is prescribed, our 503A pharmacy partner dispenses it under its own DEA registration. The prescribing decision rests with the licensed practitioner.